Czech/SlovakiaCzech RepublicSlovakia

AbCheck pockets pharma deal

03.11.2010

Plzen – Czech antibody discovery and development specialist AbCheck s.r.o. has signed its first contract with a big pharma company. In October, the yearling Czech spin-off from German antibody drug developer Affimed GmbH announced an anti­body discovery deal with Eli Lilly and Company. Under the terms of the agreement, AbCheck will use its three antibody discovery libraries, which are comprised of 10 billion structurally diverse proteins, to deliver fully human antibodies against diverse IgM, semi-synthetic and fully synthetic library display antibodies as scFv on the surface of phage particles. Lilly will receive all rights concerning the antibodies from AbCheck, which in return will receive discovery fees and development milestones totalling an undisclosed amount, according to the contract negotiated with IP consultants from Freshfields Bruckhaus Deringer. The Plzen-based antibody service company took over IP antibody discovery processes – from early stage research to lead optimisation – from Affimed, which is focussed on developing its pipeline of preclinical tetra­valent monoclonal antibody drugs.

Czech/SlovakiaCzech RepublicSlovakia

29.01.2006

Velhartice - At the end of December 2005 Vesa a.s. and the Institute of Experimental Botany of the Czech Academy of Science, Prague, announced the planned release into the environment of genetically modified potatoes with...

Czech/SlovakiaCzech RepublicSlovakia

29.01.2006

Prague - The Czech Institute of Experimental Botany and photo-ageing products specialist Senetek PLC, Napa, USA, have extended a co-operation agreement, initially limited to medical skincare applications of cytokinins, enabling...

Czech/SlovakiaCzech RepublicSlovakia

29.01.2006

Prague - The International Association of Pharmaceutical Companies (MAFS) in the Czech Republic has re-elected Petr Svoboda, head of Novartis in the Czech and Slovak Republics, as chairman. The association also elected a new...

Czech/SlovakiaCzech RepublicSlovakia

26.11.2005

Bucharest - Anti-GM activists of Greenpeace have started another campaign against the cultivation of genetically modified crops, now in Romania. At a press conference, held by the organization at the beginning of October in...

Czech/SlovakiaCzech RepublicSlovakia

26.11.2005

Brno - The Masaryk University (MU) in early-October inaugurated its new Integrated Laboratories of Biomedical Technologies (ILBIT).The European Investment Bank (EIB) - the European Union's project financing bank - had granted a...

Czech/SlovakiaCzech RepublicSlovakia

26.11.2005

Brno - The South Moravian Innovation Centre (JIC) opened a biotechnology internet portal in late-September. The web site www.gate2biotech.com is intended to provide companies, offices, and research teams with comprehensive...

Czech/SlovakiaCzech RepublicSlovakia

26.11.2005

Brno - MendelNet '05 Agro, a conference dedicated to undergraduate and postgraduate students, will be held on November 29, 2005, at Mendel University of Agriculture and Forestry focussing on the latest advances of gene technology...

Czech/SlovakiaCzech RepublicSlovakia

28.09.2005

Prague - In 2005, Czech farmers were allowed for the first time to plant Bt corn (MON 810), which is marketed under the name 'YieldGard Cornborer' and distributed by Pioneer Hi-Bred. As a result, this fall over 60 farmers will...

Czech/SlovakiaCzech RepublicSlovakia

28.09.2005

Prague - Zentiva N.V. announced in mid-September the signing of an agreement for the acquisition of 51% of S.C. Sicomed S.A., the number-one generics company in Romania, via the acquisition of Venoma Holdings Ltd. for $102...

Czech/SlovakiaCzech RepublicSlovakia

12.08.2005

Kourim - The growing popularity of the Czech Republic within the biotech community was underlined by the decision of Swiss Lonza Biotec to expand its production facilities there. Lonza Biotec has invested Euro117 million in the...

Displaying results 41 to 50 out of 70

< Previous 41-50 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-czech-slovakia/browse/4/article/abcheck-pockets-pharma-deal.html

Image Gallery

Stock list

All quotes

TOP

  • PHARMING (NL)0.53 EUR12.8%
  • BAVARIAN NORDIC (D)14.56 EUR10.3%
  • NICOX (F)2.44 EUR7.5%

FLOP

  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.3%
  • GENFIT (F)22.42 EUR-8.1%
  • DEINOVE (F)12.96 EUR-5.3%

TOP

  • BIOTECH PHARMACON (N)17.50 NOK59.1%
  • WILEX (D)0.92 EUR53.3%
  • E-THERAPEUTICS (UK)28.00 GBP40.0%

FLOP

  • CYTOS (CH)0.17 CHF-93.8%
  • BIONOR PHARMA (N)2.11 NOK-44.9%
  • PROTHENA PLC (IE)28.07 USD-40.8%

TOP

  • SILENCE THERAPEUTICS (UK)256.00 GBP6221.0%
  • IXICO (UK)71.50 GBP810.8%
  • PHARMING (NL)0.53 EUR783.3%

FLOP

  • CYTOS (CH)0.17 CHF-95.8%
  • EVOCUTIS (UK)0.22 GBP-92.5%
  • AGENNIX (D)0.04 EUR-77.8%

No liability assumed, Date: 19.04.2014

Current issue

All issues

Product of the week

Products

Events

All Events

Partner-Events

München

BioVaria 2014

Frankfurt am Main

7th DVFA Life Science Conference

White Paper